RESUMEN
In 167 patients with complete occlusion (greater than 3 cm) of the femoropopliteal artery, percutaneous transluminal laser angioplasty (PTLA) was performed after an unsuccessful attempt at crossing with a guide wire and was immediately followed by balloon dilatation. An Nd-YAG laser and an optical fiber delivery system with a sapphire tip serving as a contact probe were used for PTLA. In 132 of 167 (79%) patients, the occluded segment was successfully reopened. Clinical symptoms improved in 126 of 167 (75%) patients. PTLA was unsuccessful in 35 patients, and in 15 of these, injury of the vessel wall occurred. In one patient, surgical drainage of a large hematoma became necessary. All patients in whom recanalization had been achieved were randomized to receive long-term treatment with either phenprocumarol or acetylsalicylic acid (ASA) plus dipyridamole to prevent rethrombosis. At 36 months of follow-up, the cumulative patency rate (CPR) was 63%. A complete reobstruction in 32 patients (24%) and a partial reobstruction in 15 patients (11%) were found angiographically. The CPR after 36 months was significantly lower (p less than 0.05) in patients younger than 60 years of age (54%) than in patients older than 60 (68%); it was also significantly lower (p less than 0.05) in patients with reduced peripheral runoff (55%) due to obstructed arteries of the lower leg than in patients with unaffected runoff (73%). The CPR was 65% in recanalized segments shorter than 7 cm and was 62% in recanalized segments longer than 7 cm.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Angioplastia de Balón , Angioplastia por Láser , Arteriopatías Oclusivas/terapia , Anciano , Aspirina/uso terapéutico , Dipiridamol/uso terapéutico , Femenino , Arteria Femoral , Estudios de Seguimiento , Humanos , Masculino , Fenprocumón/uso terapéutico , Arteria Poplítea , Recurrencia , Factores de TiempoRESUMEN
This study was performed to evaluate the acute effects of two anthracycline derivatives, doxorubicin and 4'O-tetrahydropyranyl-doxorubicin [(THP)-doxorubicin], on the conduction intervals, heart rate and refractoriness of isolated spontaneously beating guinea-pig hearts using a high-resolution ECG recording technique (SST-ECG). Doxorubicin as well as (THP)-doxorubicin were added to the perfusate in increasing concentrations of 0.1, 1 and 10 microM. Doxorubicin did not significantly alter the heart rate or conduction intervals. Only the rate-dependent QT interval was significantly shortened under the influence of 10 microM doxorubicin. In contrast, 10 microM (THP)-doxorubicin led to a significant reduction in the heart rate (-13% +/- 3%; P less than 0.01, n = 7) and to a prolongation of atrioventricular conduction time (24% +/- 10%; P less than 0.05, n = 7). The rate-dependent repolarization period (QT interval) was only insignificantly shortened in the presence of 10 microM (THP)-doxorubicin. The maximal following frequencies of each part of the conduction system were not changed by 10 microM doxorubicin. In the presence of (THP)-doxorubicin, the maximal following frequency of the ventricular myocardium was increased by as much as 36% +/- 8% (P less than 0.01, n = 7), indicating a shortening of the effective refractory period of the ventricular myocardium (V-ERP). These results show that the activation of (THP)-doxorubicin resembles the effects of Ca-antagonistic compounds on the heart (i.e. decrease in the spontaneous sinus rate and prolongation of the AV-nodal conduction interval). Changes in the QT interval exerted by doxorubicin and the shortening of the ventricular effective refractory period by (THP)-doxorubicin may indicate an alteration of the K(+)-conductance of the membrane. As the acute electrophysiological effects of doxorubicin and (THP)-doxorubicin are modest and occur only at excessive concentrations (10 microM), a direct influence on the generation of arrhythmias in healthy hearts is unlikely.
Asunto(s)
Antibióticos Antineoplásicos/farmacología , Corazón/efectos de los fármacos , Animales , Estimulación Cardíaca Artificial , Relación Dosis-Respuesta a Droga , Doxorrubicina/análogos & derivados , Doxorrubicina/farmacología , Electrocardiografía/efectos de los fármacos , Electrofisiología , Femenino , Cobayas , Corazón/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Frecuencia Cardíaca/fisiología , Técnicas In Vitro , Masculino , Factores de TiempoRESUMEN
An 18-year-old male presented with Raynaud's phenomenon which was found to be caused by occlusion of the proper palmar digital arteries on the right hand and obstruction of the superficial palmar arterial arch on the left hand. These lesions in the arteries of both hands resemble those found in patients with vibration-induced white fingers such as in mine or foundry workers. The only likely cause for the pathological vascular findings in our patient was an exposure to vibration due to excessive off-street motorcycle driving. Therapy with intraarterial prostaglandins resolved the ischemic syndrome but it promptly recurred when the patient resumed motor cycle driving. Therefore, we suggest that excessive cross country motor cycle driving may cause vibration-induced white fingers.
Asunto(s)
Dedos/irrigación sanguínea , Motocicletas , Enfermedad de Raynaud/diagnóstico por imagen , Adolescente , Aneurisma/diagnóstico por imagen , Arteriopatías Oclusivas/diagnóstico por imagen , Humanos , Masculino , Radiografía , Vibración/efectos adversosRESUMEN
The optical isomers of the beta blocking agent propranolol exert beta receptor blocking as well as membrane stabilizing effects. The latter is thought to be responsible for the antiarrhythmic effect of the drug. In this study we quantified the electrophysiological effects of both isomers of propranolol on the conduction and pacemaker system of the heart. The experiments were performed on isolated hearts using a special ECG recording and stimulation technique. To abolish isoproterenol's beta adrenergic stimulatory effect on heart rate, 30-times higher concentrations of (+)propranolol were necessary than of (-)propranolol in order to be consistent. Both isomers caused a similar and marked slowing of conduction velocity through the bundle of His and ventricular myocardium. Also, heart rate, as well as atrio-ventricular conduction velocity were significantly slowed by a concentration of 10 microM of either drug, (-)propranolol being slightly more effective. Only in the presence of (-)propranolol did significant changes of atrio-ventricular and His-bundle conduction occur at a concentration of 1 microM. During programmed stimulation sinus node recovery time was more prolonged by (-)propranolol than during perfusion with (+)propranolol. The highest rate of pacing with 1:1 conduction of the sino-atrial conduction, the atrial and ventricular myocardium was significantly depressed to a comparable degree by either isomers of propranolol. These effects appear to be primarily responsible for the antiarrhythmic effects of both isomers. Because of the minor effects of (+)propranolol on sinus- and AV-node activity, as well as on beta adrenergic receptors, this isomer may have potential clinical importance in the treatment of arrhythmias.
Asunto(s)
Corazón/efectos de los fármacos , Propranolol/farmacología , Animales , Estimulación Cardíaca Artificial , Electrocardiografía , Femenino , Cobayas , Corazón/fisiología , Sistema de Conducción Cardíaco/efectos de los fármacos , Sistema de Conducción Cardíaco/fisiología , Frecuencia Cardíaca/efectos de los fármacos , Técnicas In Vitro , Isoproterenol/farmacología , Masculino , EstereoisomerismoRESUMEN
This study was performed to evaluate the direct effects of magnesium ions on cardiac conduction velocities and on refractoriness using a modified Langendorff perfusion system and a special ECG recording and stimulation technique. An increase of the MG2+ concentration to 2.3 mM had no detectable effects. Higher concentrations of up to 4.6 mM decreased the spontaneous sinus rate and the conduction velocity through the AV node and the His bundle in a concentration-dependent manner. During stimulation with premature beats, in the presence of 4.6 mM of Mg2+, the effective and relative refractory periods (ERP, RRP) of sinoatrial, AV nodal, and His bundle conduction and the ERP of the ventricular myocardium were significantly prolonged, whereas the ERP of the atrial myocardium remained unaffected. The refractoriness of sinoatrial, AV nodal, and His bundle conduction, and of the ventricular myocardium, were also prolonged during pacing with a stepwise increased pacing rate. These observations suggest a marked rate-dependent inhibitory effect of magnesium on the refractoriness of the His-bundle conduction and of the ventricular myocardium, which might be an important factor in the antiarrhythmic effectiveness of magnesium in ventricular tachyarrhythmias.
Asunto(s)
Corazón/efectos de los fármacos , Magnesio/farmacología , Animales , Nodo Atrioventricular/efectos de los fármacos , Fascículo Atrioventricular/efectos de los fármacos , Complejos Cardíacos Prematuros/fisiopatología , Estimulación Eléctrica , Electrocardiografía , Electrofisiología , Femenino , Cobayas , Sistema de Conducción Cardíaco/efectos de los fármacos , Técnicas In Vitro , Masculino , Periodo Refractario Electrofisiológico/efectos de los fármacos , Nodo Sinoatrial/efectos de los fármacosAsunto(s)
Alprostadil/administración & dosificación , Arteriopatías Oclusivas/terapia , Isquemia/terapia , Pierna/irrigación sanguínea , Activador de Tejido Plasminógeno/administración & dosificación , Quimioterapia Combinada , Humanos , Infusiones Intraarteriales , Proteínas Recombinantes/administración & dosificaciónRESUMEN
The effects of magnesium ions on the cardiac conduction velocity and on the refractory periods of the single parts of Langendorff perfused guinea pig hearts were studied using a high amplifying ECG recording and a special stimulation technique. Concentrations of 2.3 mM or 3.45 mM Mg++ had only little inhibitory effects on the cardiac conduction velocity and on the sinus node activity. The elevation of the magnesium ion concentration to 4.6 mM caused a reduction of the spontaneous sinus rate and a prolongation of the AV nodal and His bundle conduction time. During stimulation with stepwise increasing pacing rate, a marked prolongation of the refractoriness of the His bundle conduction and of the ventricular myocardium was detectable. This frequency dependent inhibitory influence on the His bundle and the ventricular myocardium could be an explanation for the antiarrhythmic efficacy of magnesium ions during ventricular tachyarrhythmias.
Asunto(s)
Nodo Atrioventricular/efectos de los fármacos , Electrocardiografía , Sistema de Conducción Cardíaco/efectos de los fármacos , Magnesio/farmacología , Animales , Fascículo Atrioventricular/efectos de los fármacos , Estimulación Cardíaca Artificial , Relación Dosis-Respuesta a Droga , Femenino , Cobayas , MasculinoRESUMEN
Prostaglandin E 1 has been used for the past 15 years in decreased peripheral arterial perfusion with differing degrees of success. The exact mechanism of action has not been clarified so far. Vasodilatation, increased fibrinolytic activity and an improved cellular metabolism were observed in response to PGE 1 in animal experiments both in vivo and in vitro. In the clinical studies performed so far PGE 1 has been used in cases of decreased peripheral arterial perfusion after functional, inflammatory, degenerative or diabetic arteriopathy (stages IIb-IV). Reduction or alleviation of ischaemic rest pain, as well as a faster healing of tissue necrosis was reported after intaarterial administration, especially in non-controlled, but also in controlled studies. Intravenous administration of PGE 1 had a positive influence on clinical symptoms in non-placebo-randomized patients; in the controlled studies, however, the results were not significant. The greatest therapeutic success can be achieved using intermittent intraarterial administration in decreased peripheral arterial perfusion due to functional or inflammatory arteriopathies.
Asunto(s)
Alprostadil/uso terapéutico , Arteriopatías Oclusivas/tratamiento farmacológico , Ensayos Clínicos como Asunto , Humanos , Distribución AleatoriaRESUMEN
Percutaneous transluminal laser angioplasty was carried out for the dilatation of 30 completely occluded peripheral arterial segments and three subtotal stenoses. A neodymium-YAG laser and an optical fibre delivery system with a sapphire tip were used. All three arterial stenoses and 26 of the 30 occluded arterial segments were successfully dilated. In 20 patients additional dilatation was carried out with a balloon catheter. Laser angioplasty failed to recanalise four occlusions, and vessel leakage without clinical consequences occurred in one patient. Reocclusion occurred within 48 h in two patients and after five months in one patient during a follow up period of at least six months. It is concluded that percutaneous transluminal laser angioplasty using direct contact with a sapphire tip is highly effective (89% success rate) in reopening peripheral vascular occlusions. The procedure is safe, and reocclusion of vessels is rare during the six month follow up period.
Asunto(s)
Angioplastia de Balón/instrumentación , Arteriopatías Oclusivas/terapia , Terapia por Láser , Adulto , Anciano , Anciano de 80 o más Años , Angioplastia de Balón/métodos , Femenino , Humanos , Masculino , Persona de Mediana EdadAsunto(s)
Enfermedades de la Aorta/terapia , Glicoproteínas/sangre , Isquemia/terapia , Pierna/irrigación sanguínea , Activadores Plasminogénicos/antagonistas & inhibidores , Inactivadores Plasminogénicos , Estreptoquinasa/uso terapéutico , Tromboflebitis/terapia , Trombosis/terapia , Activador de Tejido Plasminógeno/uso terapéutico , Humanos , Isquemia/sangre , Proteínas Recombinantes/uso terapéutico , Tromboflebitis/sangreAsunto(s)
Electrocardiografía , Sistema de Conducción Cardíaco/efectos de los fármacos , Estreptoquinasa/toxicidad , Activador de Tejido Plasminógeno/toxicidad , Activador de Plasminógeno de Tipo Uroquinasa/toxicidad , Animales , Relación Dosis-Respuesta a Droga , Cobayas , Perfusión , Proteínas Recombinantes/toxicidadAsunto(s)
Enfermedades de la Aorta/terapia , Isquemia/terapia , Pierna/irrigación sanguínea , Trombosis/terapia , Activador de Tejido Plasminógeno/administración & dosificación , Adulto , Aorta Abdominal , Ensayos Clínicos como Asunto , Femenino , Humanos , Arteria Ilíaca , Masculino , Persona de Mediana Edad , Distribución Aleatoria , Proteínas Recombinantes/administración & dosificación , Estreptoquinasa/administración & dosificación , Activador de Plasminógeno de Tipo Uroquinasa/administración & dosificaciónAsunto(s)
Arteriopatías Oclusivas/cirugía , Isquemia/cirugía , Terapia por Láser , Pierna/irrigación sanguínea , Adulto , Anciano , Anciano de 80 o más Años , Angioplastia de Balón , Femenino , Arteria Femoral/cirugía , Humanos , Masculino , Persona de Mediana Edad , Arteria Poplítea/cirugía , RecurrenciaAsunto(s)
Óxido de Aluminio , Aluminio , Angioplastia de Balón/instrumentación , Arteriopatías Oclusivas/cirugía , Isquemia/cirugía , Terapia por Láser/instrumentación , Pierna/irrigación sanguínea , Adulto , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
In order to investigate and compare the fibrinolytic activity of streptokinase, streptokinase-Glutamine-plasminogen, and urokinase for intraarterial fibrinolysis, as in vitro test and a prospective trial were performed. For the in vitro demonstration of lytic activity, fibrin plates with plasminogen and fibrin plates without plasminogen were incubated with streptokinase; with streptokinase-plasminogen in molar proportions of 1:1, 1:2, and 2:1, and with urokinase. In order to examine the in vivo activity of the different lytic solutions, 98 patients suffering from peripheral arterial occlusions were divided into three homogeneous groups for treatment with streptokinase, streptokinase-plasminogen, and urokinase. Although urokinase was superior to streptokinase on the fibrin plate with plasminogen, no difference was demonstrated in vivo between the two lytic agents. Streptokinase-plasminogen in a molar proportion of 1:2 showed significantly higher fibrinolytic activity than any other solution. Therefore, the fibrinolytic agent of choice for intrathrombotic injections seems to be a 1:2 solution of streptokinase with plasminogen or with the lytic enzyme plasmin itself.